Attacks on medical care
Khartoum: Aid in jeopardy as MSF staff face beatings, death threats and theft
MSF has treated over 1,600 war wounded patients in Khartoum since the conflict began and our intentions are to continue to do this. However, the security situation has deteriorated so dramatically over the past few weeks that our presence in the Turkish Hospital is now in question. Press Release - 21 Jul 2023
Malnutrition
Influx of Sudanese refugees in eastern Chad: children threatened by malnutrition and measles
Last week, up to 286 children were taken care of in the wards of the Adré paediatric hospital where MSF teams work - by comparison, around fifty children were being treated at the same time last year. Update - 20 Jul 2023
Cholera
DRC: Emergency response against cholera in the territory of Rutshuru
Médecins Sans Frontières (MSF) / Doctors Without Borders teams have been mobilised urgently in the territory of Rutshuru, in the East of the Democratic Republic of Congo, in response to an outbreak of suspected cases of cholera, particularly in the Binza and Rutshuru health zones. More than 1,500 patients have been treated since the beginning of June 2023. Article - 20 Jul 2023
Refugees, Migration and displacement
Refugees' Journey from Khartoum to the Camps in East Sudan
For Ethiopian refugees like Salim* and Qamar*, who had already experienced escaping violence in their homeland, their journey from Khartoum to east Sudan was fraught with risks. They recounted the strenuous details of their journey with their four children after arriving at their second resettlement in camp in East Sudan, where MSF is providing medical and emergency support Article - 18 Jul 2023
Access to medicines
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
As Johnson & Johnson’s (J&J) 20-year primary patent on the critical, lifesaving drug-resistant tuberculosis (DR-TB) drug bedaquiline expires in majority of countries including India today, MSF reiterated its call for the US pharmaceutical corporation to publicly announce it will not enforce any ‘secondary’ patents for the drug in any country with a high burden of TB, and withdraw and abandon all pending secondary patent applications for this critical drug everywhere. Press Release - 18 Jul 2023
Measles
CAR: MSF vaccinates thousands of children after arrival of refugees from Sudan
This vaccination campaign against measles and other diseases is part of the emergency response launched by the medical organization in the town of Birao, in northern Central African Republic, where refugees from Sudan have been relocated. Update - 17 Jul 2023
Cholera
Why is cholera killing hundreds across the Horn of Africa when it is so preventable?
Cholera outbreaks are occurring with increasing frequency, and lasting for longer, across Somalia, Kenya and Ethiopia. Tetiana Gaviuk, MSF communications manager questions in this piece why the death toll from this preventable disease is rising. Article - 14 Jul 2023
Access to Healthcare
Sudan: Over 1,000 wounded people treated at MSF-supported hospital during almost three months of fighting in El Fasher
Since the start of the fighting in Sudan, MSF and Ministry of Health staff have treated over 1,000 war wounded patients at the hospital MSF supports in North Darfur. Here, Mohammed Alfa-qeeh – our project coordinator in El Fasher – describes the current situation in the city Stories from the Frontline - 14 Jul 2023
Access to Healthcare